Artivion, Inc.
AORT
Jodie situation report
Artivion, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 11 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.
- AORT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if AORT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind AORT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BAXBaxter International Inc.supplierFeb 18, 2026 ▾
“We began to manufacture and supply PerClot ® hemostatic powder (“PerClot”) during the second quarter of 2023 (as part of our Transitional Manufacturing and Supply Agreement with Baxter International, Inc.).”
ABTAbbott LaboratoriescompetitorMay 8, 2026 ▾
“On-X heart valves compete primarily with mechanical valves from Abbott Laboratories, Medtronic, plc.”
Depended on by
LMATLeMaitre Vascular, Inc.competitorFeb 26, 2026 ▾
“Notable larger competitors include Abbott; Baxter; Artivion; Becton Dickinson; Edwards Lifesciences; Getinge; LifeNet Health; Terumo; and W.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 15 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AORT is currently a Early Follower in the organic co-movement group Healthcare Real Estate. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for AORT; it is not active in the latest market snapshot.